Alphabiome.ai

Indonesia
Kador, Riau, Indonesia

Company profile

Alphabiome.ai company profile

Alphabiome uses artificial intelligence to decode the genetic complexity of the human microbiome and identify biomarkers that predict treatment efficacy. Alphabiome’s mission is to unlock the full potential of the microbiome to transform how diseases are understood, diagnosed, and treated . Its proprietary technology enables large-scale, reference-free analysis of microbial DNA – converting trillions of untapped genetic fragments into actionable insights for drug development, clinical decision-making, and precision medicine.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2022-03-01, Month

Headquarters

Country code
ID
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$8M
Last funding
Seed / $8M / 2025-05-06
Last equity funding
Seed / $8M
Investors
2
Lead investors
2
Founders
2

Founders and investors

Founders

Alex PentlandYaniv Altshuler

Lead investors

AIX VenturesNew Era Capital Partners

Investors

AIX VenturesNew Era Capital Partners